glp 1 blurry vision GLP-1 Medications and NAION: What Patients Should Know About Sudden Loss tirzepatide and blurry vision Focus

McGowan, M

Keywords: GLP1, obesity, adolescents, GLP1 dual agonist, GLP1 triple agonist, diabetes Introduction The Growing Burden of Adolescent Obesity With prevalence rates rising sharply over the past few decades, adolescent obesity has emerged as a major global public health challenge

This 16-week window captures the period when pregnancy may be unrecognized and encompasses early organogenesis

To reduce the risk of gastrointestinal side effects, a gradual escalation of doses is recommended

135 Tirzepatide is developed by Eli Lilly and has proven to provide superior blood sugar control and significant weight loss, making it particularly valuable in the treatment of T2DM

The findings support the idea that treating obesity and metabolic dysfunction with GLP-1 drugs could help restore hormonal balance and reproductive function in both women and men